TipRanks
Lineage Cell Therapeutics, Inc. (DE:BT3)
FRANKFURT:BT3

Compare Lineage Therap (BT3) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Lineage Therap
€0.92
€211.64M
-6.76
-40.50%
5 Buy
0 Hold
0 Sell
Strong Buy
Amarin
$14.15
$254.95M
-8.41
-37.62%
0 Buy
0 Hold
1 Sell
Moderate Sell
Tvardi Therapeutics
$1.82
$14.41M
-0.39
-97.27%
4 Buy
1 Hold
1 Sell
Moderate Buy
DBV Technologies SA - American
$14.97
$623.92M
-2.55
-31.39%
4 Buy
0 Hold
0 Sell
Strong Buy
4D Molecular Therapeutics
$14.91
$693.87M
-4.63
51.32%
9 Buy
1 Hold
0 Sell
Strong Buy
Aura Biosciences Inc
$7.82
$639.86M
-3.63
12.15%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:BT3
Lineage Therap
0.83
-0.62
-42.55%
AMRN
Amarin
12.02
-7.05
-36.97%
TVRD
Tvardi Therapeutics
1.10
-41.88
-97.44%
DBVT
DBV Technologies SA - American
9.77
-6.10
-38.44%
FDMT
4D Molecular Therapeutics
12.59
3.03
31.69%
AURA
Aura Biosciences Inc
6.46
0.43
7.13%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts